ovine adenovirus (HepaVec/CSIRO)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug Nameovine adenovirus (HepaVec/CSIRO)
Drug Alias NameOAdV220ovine adenovirus (gene therapy)OAdV218gene therapy (HepaVec/CSIRO)
ClassificationBiologics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLiver DiseasesProstatic NeoplasmsLiver Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New ZealandGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCommonwealth Scientific And Industrial Research Organisation, Australia
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCommonwealth Scientific And Industrial Research Organisation, AustraliaHepaVec AG fuer Gentherapie
Active IndicationsN/A
Inactive IndicationsLiver DiseasesProstatic NeoplasmsLiver Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A